Foundation HealthCare Year To Date Revenue Grows 32% To $94 Million; Adjusted EBITDA Increased 93% To $10.8 Million
OKLAHOMA CITY, Nov. 2, 2015 /PRNewswire/ -- Foundation HealthCare, Inc. (OTCQB: FDNH), which is an owner and operator of surgical hospitals, announced today the Company's financial results for the third quarter of 2015.
Highlights include:
- Net revenues increased 19% for the third quarter to $32.6 million and 32% year-to-date to $94.0 million.
- Adjusted EBITDA increased 43% to $5.0 million for the third quarter and 93% to $10.8 million year-to-date.
- Patient service revenue grew by 24% at majority owned hospitals in the third quarter, 37%year-to-date.
- Fifth consecutive quarter that the company reported double digit growth compared to 2014.
"Patient care is our number one priority at Foundation HealthCare and a key differentiator in our business model," said Stanton Nelson, CEO of Foundation HealthCare. "Our physician partners and our clinical teams continue to perform at a high level which is why we believe our patient satisfaction scores are some of the highest in the country."
Foundation HealthCare reported impressive growth during the first half of 2015 and continued that in the third quarter, reporting 19% revenue growth in the third quarter compared to 2014 and year-to-date growth of 32% compared to the same period in 2014. Foundation has reported five consecutive quarters with double digit growth.
"Patient service revenues grew 23% in the third quarter of 2015 compared to the same period last year. Year-to-date growth in patient service revenues has been 37%," said Nelson. "This continued revenue growth validates our business strategy of recruiting top tier physicians, providing our patients with an unparalleled health experience and expanding ancillary services."
"The fourth quarter has historically been one of Foundation's best earnings periods so we expect these positive trends to continue," said Nelson.
Third Quarter 2015 Financial Results:
Net revenues and equity in earnings of affiliates in the third quarter of 2015 were collectively $32.8 million, up 17% from $28.0 million in the third quarter of 2014. Our net revenues are composed of patient services, less our provision for doubtful accounts, management fees from affiliates and other revenue. Patient services revenue (net of the provision for doubtful accounts) increased $5.8 million, or 23%, to $30.4 million during the three months ended September 30, 2015 as compared to $24.6 million in the same period of 2014. The increase was primarily due to increased revenue at our El Paso hospital generated by more complex cases and increased revenues from ancillary services.
Operating expenses for the third quarter of 2015 were $29.6 million compared to $26.1 million in the third quarter of 2014. The increase is due primarily to increased purchased services cost directly related to the increased net revenues generated from ancillary services.
Our operations resulted in a net income attributable to Foundation HealthCare common stock of $0.3 million during the third quarter of 2015, compared to a net income of $0.2 million during the third quarter of 2014. Earnings per share from continuing operations for the three months ended September 30, 2015 was $0.02 compared to an earnings per share of $0.01 per share in the prior year.
Adjusted EBITDA was $5.0 million for the 2015 third quarter compared to $3.5 million in the third quarter of 2014.
Year-To-Date 2015 Financial Results:
Net revenues for the nine months ended September 30, 2015 were $94.0 million, up 32% from $71.1 million reported in the first nine months of 2014. Patient services revenue (net of the provision for doubtful accounts) increased $23.1 million, or 37 percent, to $85.9 million during the nine months ended September 30, 2015 as compared to $62.8 million in the same period of 2014.
The increase was primarily due to increased revenue at our El Paso hospital generated by more complex cases and increased revenues from ancillary services.
Operating expenses for the first nine months of 2015 were $88.9 million compared to $72.7 million in the first nine months of 2014. The increase is due primarily to increased purchased services cost directly related to the increased net revenues generated from ancillary services.
Our operations, including the gain on the sale of our minority interest in the Sherman, Texas hospital resulted in a net income attributable to Foundation HealthCare common stock of $3.5 million during the first nine months of 2015, compared to a net loss of $3.2 million during the first nine months of 2014. Net loss per share from continuing operations for the nine months ended September 30, 2015 was $0.02 compared to a net loss per share of $0.17 per share in the prior year.
Year-To-Date Adjusted EBITDA as of September 30, 2015 was $10.8 million compared to $5.6 million for first nine months of 2014.
At September 30, 2015, cash and cash equivalents totaled $4.8 million, compared to $2.9 million at December 31, 2014.
Conference Call
Foundation's CEO Stanton Nelson, and CFO, Hugh King will host a conference call today, followed by a question and answer period.
Date: Nov. 2, 2015
Time: 4:30 p.m. Eastern time
Dial-In Number: (888) 348-6454
The conference call will be broadcast live at the investor relations section of the Company's website at www.fdnh.com. Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. In addition, the replay will be available after the call at same website link above or by calling (877) 870-5176 using passcode: 10075178.
About Foundation HealthCare
Headquartered in Oklahoma City, Foundation HealthCare, Inc. (OTCQB: FDNH) owns and operates surgical hospitals including ancillary hospital based services. These additional services, such as hyperbaric medicine, sleep labs, intra-operative monitoring, imaging and robotic surgery, truly make the Foundation specialty hospital environment unique.
The Company is also an industry leading ASC management and development company focused on partnering with physicians and employees to create an outstanding patient experience, while maximizing partner and shareholder value. The Company is a leader in offering turnkey management and development solutions for physician partners, as well as creating an optimal experience for the patients we serve. For more information, visit www.fdnh.com.
Reg G disclaimer – reconciling GAAP Net Income with EBITDA and Adjusted EBITDA
Foundation is providing EBITDA information, which is defined as net income plus interest, income taxes, depreciation and amortization expense and earnings or losses from discontinued operations, and Adjusted EBITDA which is defined as EBITDA plus impairment charges minus non-recurring gains. EBITDA and Adjusted EBITDA are a complement to our GAAP results. EBITDA and Adjusted EBITDA are commonly used by management and investors as a measure of leverage capacity, debt service ability and liquidity. EBITDA and Adjusted EBITDA are not considered a measure of financial performance under U.S. generally accepted accounting principles (GAAP), and the items excluded from EBITDA and Adjusted EBITDA are significant components in understanding and assessing our financial performance. EBITDA and Adjusted EBITDA should not be considered in isolation or as an alternative to, or superior to, such GAAP measures as net income, cash flows provided by or used in operating, investing or financing activities or other financial statement data presented in our consolidated financial statements as an indicator of financial performance or liquidity. Reconciliations of non-GAAP financial measures are provided in the news release in the accompanying tables. Since EBITDA and Adjusted EBITDA are not a measure determined in accordance with GAAP and is susceptible to varying calculations, EBITDA, and Adjusted EBITDA as presented, may not be comparable to other similarly titled measures of other companies.
Important Cautions Regarding Forward-Looking Statements
This press release contains forward-looking statements that are based on the Company's current expectations, forecasts and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the Company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not in the control of the Company, including, without limitation, the risk that Company will maintain enough liquidity to execute its business plan, continue as a going concern and other risks including those enumerated and described in the Company's filings with the Securities and Exchange Commission, which filings are available on the SEC's website at www.sec.gov. Unless otherwise required by law, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Company Contact:
Foundation HealthCare, Inc.
Stanton Nelson, CEO
Tel 405-608-1715
FOUNDATION HEALTHCARE, INC.
Reconciliation of Income (Loss) from Continuing Operations to EBITDA from Continuing Operations |
|||||||||||||||
For the Three Months Ended |
For the Nine Months Ended |
||||||||||||||
September 30, |
September 30, |
||||||||||||||
2015 |
2014 |
2015 |
2014 |
||||||||||||
Income (loss) from continuing operations, net of taxes |
$ |
3,097,905 |
$ |
1,646,310 |
$ |
5,402,130 |
$ |
(274,649) |
|||||||
EBITDA adjustments: |
|||||||||||||||
Plus: Interest expense, net |
221,881 |
324,700 |
827,204 |
1,329,932 |
|||||||||||
Plus: Provision (benefit) for income taxes |
— |
— |
(114,038) |
(852,005) |
|||||||||||
Plus: Depreciation and amortization |
1,345,340 |
1,320,527 |
4,072,795 |
4,204,828 |
|||||||||||
Total EBITDA adjustments |
1,567,221 |
1,645,227 |
4,785,961 |
4,682,755 |
|||||||||||
EBITDA from continuing operations |
$ |
4,665,126 |
$ |
3,291,537 |
$ |
10,188,091 |
$ |
4,408,106 |
|||||||
EBITDA from continuing operations |
$ |
4,665,126 |
$ |
3,291,537 |
$ |
10,188,091 |
$ |
4,408,106 |
|||||||
Adjusted EBITDA adjustment |
|||||||||||||||
Plus: Stock compensation expense |
286,259 |
185,171 |
634,865 |
1,191,286 |
|||||||||||
Total Adjusted EBITDA adjustments |
286,259 |
185,171 |
634,865 |
1,191,286 |
|||||||||||
Adjusted EBITDA |
$ |
4,951,385 |
$ |
3,476,708 |
$ |
10,822,956 |
$ |
5,599,392 |
FOUNDATION HEALTHCARE, INC.
Condensed Consolidated Balance Sheets |
|||||||
September 30, |
December 31, |
||||||
2015 |
2014 |
||||||
ASSETS |
|||||||
Cash and cash equivalents |
$ |
4,751,278 |
$ |
2,860,025 |
|||
Accounts receivable, net of allowance for doubtful accounts of $1,184,000 and $1,742,000, respectively |
21,321,016 |
18,971,435 |
|||||
Receivables from affiliates |
524,479 |
1,157,184 |
|||||
Supplies inventories |
1,912,887 |
1,863,175 |
|||||
Prepaid and other current assets |
3,187,300 |
4,487,873 |
|||||
Current assets from discontinued operations |
246,011 |
342,441 |
|||||
Total current assets |
31,942,971 |
29,682,133 |
|||||
Property and equipment, net |
11,962,955 |
13,465,190 |
|||||
Equity method investments in affiliates |
2,909,701 |
3,558,020 |
|||||
Intangible assets, net |
7,536,727 |
9,080,395 |
|||||
Goodwill |
973,927 |
973,927 |
|||||
Other assets |
535,704 |
437,809 |
|||||
Other assets from discontinued operations |
792,184 |
2,329,395 |
|||||
Total assets |
$ |
56,654,169 |
$ |
59,526,869 |
|||
LIABILITIES, PREFERRED NONCONTROLLING INTEREST AND SHAREHOLDERS' DEFICIT |
|||||||
Liabilities: |
|||||||
Accounts payable |
$ |
6,498,219 |
$ |
10,364,160 |
|||
Accrued liabilities |
11,472,795 |
10,223,388 |
|||||
Preferred noncontrolling interests dividends payable |
177,623 |
195,212 |
|||||
Short-term debt |
398,207 |
456,784 |
|||||
Current portion of long-term debt |
4,828,974 |
5,023,048 |
|||||
Other current liabilities |
1,349,586 |
1,052,543 |
|||||
Current liabilities from discontinued operations |
1,394,521 |
839,791 |
|||||
Total current liabilities |
26,119,925 |
28,154,926 |
|||||
Long-term debt, net of current portion |
18,318,716 |
24,737,719 |
|||||
Deferred lease incentive |
7,908,895 |
8,608,716 |
|||||
Other liabilities |
6,380,263 |
5,424,313 |
|||||
Total liabilities |
58,727,799 |
66,925,674 |
|||||
Preferred noncontrolling interest |
7,830,000 |
8,700,000 |
|||||
Commitments and contingencies (Note 10) |
|||||||
Foundation Healthcare shareholders' deficit: |
|||||||
Preferred stock $0.0001 par value, 10,000,000 authorized; no shares issued and outstanding |
— |
— |
|||||
Common stock $0.0001 par value, 500,000,000 shares authorized; 17,273,180 and 17,263,842 issued and outstanding, respectively |
1,727 |
1,726 |
|||||
Paid-in capital |
19,900,781 |
19,321,267 |
|||||
Accumulated deficit |
(33,718,357) |
(37,265,044) |
|||||
Total Foundation Healthcare shareholders' deficit |
(13,815,849) |
(17,942,051) |
|||||
Noncontrolling interests |
3,912,219 |
1,843,246 |
|||||
Total deficit |
(9,903,630) |
(16,098,805) |
|||||
Total liabilities, preferred noncontrolling interest and shareholders' deficit |
$ |
56,654,169 |
$ |
59,526,869 |
FOUNDATION HEALTHCARE, INC.
Condensed Consolidated Statements of Operations |
|||||||
2015 |
2014 |
||||||
Net Revenues: |
|||||||
Patient services |
$ |
31,765,408 |
$ |
26,183,803 |
|||
Provision for doubtful accounts |
(1,402,684) |
(1,562,147) |
|||||
Net patient services revenue |
30,362,724 |
24,621,656 |
|||||
Management fees from affiliates |
1,217,108 |
1,352,909 |
|||||
Other revenue |
1,017,134 |
1,450,021 |
|||||
Revenues |
32,596,966 |
27,424,586 |
|||||
Equity in earnings of affiliates |
247,223 |
581,171 |
|||||
Operating Expenses: |
|||||||
Salaries and benefits |
8,698,484 |
7,339,528 |
|||||
Supplies |
7,115,559 |
6,748,785 |
|||||
Other operating expenses |
12,445,063 |
10,655,907 |
|||||
Depreciation and amortization |
1,345,340 |
1,320,527 |
|||||
Total operating expenses |
29,604,446 |
26,064,747 |
|||||
Other Income (Expense): |
|||||||
Interest expense, net |
(221,881) |
(324,700) |
|||||
Other income |
80,043 |
30,000 |
|||||
Net other (expense) |
(141,838) |
(294,700) |
|||||
Income from continuing operations, before taxes |
3,097,905 |
1,646,310 |
|||||
Benefit for income taxes |
— |
— |
|||||
Income from continuing operations, net of taxes |
3,097,905 |
1,646,310 |
|||||
Income (loss) from discontinued operations, net of tax |
34,744 |
(83,997) |
|||||
Net income |
3,132,649 |
1,562,313 |
|||||
Less: Net income attributable to noncontrolling interests |
2,617,821 |
1,208,648 |
|||||
Net income attributable to Foundation Healthcare |
514,828 |
353,665 |
|||||
Preferred noncontrolling interests dividends |
(175,646) |
(199,502) |
|||||
Net income attributable to Foundation Healthcare common stock |
$ |
339,182 |
$ |
154,163 |
|||
Earnings per common share (basic and diluted): |
|||||||
Net income attributable to continuing operations attributable to Foundation Healthcare common stock |
$ |
0.02 |
$ |
0.01 |
|||
Income from discontinued operations, net of tax |
0.00 |
0.00 |
|||||
Net income per share, attributable to Foundation Healthcare common stock |
$ |
0.02 |
$ |
0.01 |
|||
Weighted average number of common and diluted shares outstanding |
17,271,513 |
17,182,473 |
FOUNDATION HEALTHCARE, INC.
Condensed Consolidated Statements of Operations |
|||||||
2015 |
2014 |
||||||
Net Revenues: |
|||||||
Patient services |
$ |
89,855,903 |
$ |
65,607,006 |
|||
Provision for doubtful accounts |
(4,001,230) |
(2,799,237) |
|||||
Net patient services revenue |
85,854,673 |
62,807,769 |
|||||
Management fees from affiliates |
4,440,184 |
4,056,981 |
|||||
Other revenue |
3,707,213 |
4,271,194 |
|||||
Revenues |
94,002,070 |
71,135,944 |
|||||
Equity in earnings of affiliates |
978,295 |
1,752,284 |
|||||
Operating Expenses: |
|||||||
Salaries and benefits |
24,354,308 |
22,317,768 |
|||||
Supplies |
20,575,610 |
17,383,162 |
|||||
Other operating expenses |
39,927,517 |
28,810,032 |
|||||
Depreciation and amortization |
4,072,795 |
4,204,828 |
|||||
Total operating expenses |
88,930,230 |
72,715,790 |
|||||
Other Income (Expense): |
|||||||
Interest expense, net |
(827,204) |
(1,329,932) |
|||||
Other income |
65,161 |
30,840 |
|||||
Net other (expense) |
(762,043) |
(1,299,092) |
|||||
Income (loss) from continuing operations, before taxes |
5,288,092 |
(1,126,654) |
|||||
Benefit for income taxes |
114,038 |
852,005 |
|||||
Income (loss) from continuing operations, net of taxes |
5,402,130 |
(274,649) |
|||||
Income (loss) from discontinued operations, net of tax |
3,805,801 |
(333,296) |
|||||
Net income (loss) |
9,207,931 |
(607,945) |
|||||
Less: Net income attributable to noncontrolling interests |
5,112,737 |
2,054,872 |
|||||
Net income (loss) attributable to Foundation Healthcare |
4,095,194 |
(2,662,817) |
|||||
Preferred noncontrolling interests dividends |
(548,507) |
(585,640) |
|||||
Net income (loss) attributable to Foundation Healthcare common stock |
$ |
3,546,687 |
$ |
(3,248,457) |
|||
Earnings per common share (basic and diluted): |
|||||||
Net loss attributable to continuing operations attributable to Foundation Healthcare common stock |
$ |
(0.02) |
$ |
(0.17) |
|||
Income (loss) from discontinued operations, net of tax |
0.22 |
(0.02) |
|||||
Net income (loss) per share, attributable to Foundation Healthcare common stock |
$ |
0.20 |
$ |
(0.19) |
|||
Weighted average number of common and diluted shares outstanding |
17,258,727 |
17,016,318 |
FOUNDATION HEALTHCARE, INC.
Condensed Consolidated Statements of Cash Flows |
|||||||
2015 |
2014 |
||||||
Operating activities: |
|||||||
Net income (loss) |
$ |
9,207,931 |
$ |
(607,945) |
|||
Less: Income (loss) from discontinued operations, net of tax |
3,805,801 |
(333,296) |
|||||
Income (loss) from continuing operations, net of tax |
5,402,130 |
(274,649) |
|||||
Adjustments to reconcile net income (loss) from continuing operations, net of tax, to net cash provided by operating activities: |
|||||||
Depreciation and amortization |
4,072,795 |
4,204,828 |
|||||
Stock-based compensation, net of cashless vesting |
579,515 |
876,851 |
|||||
Provision for doubtful accounts |
4,001,230 |
2,799,237 |
|||||
Equity in earnings of affiliates |
(978,295) |
(1,752,284) |
|||||
Changes in assets and liabilities: |
|||||||
Accounts receivable, net of provision for doubtful accounts |
(6,350,811) |
(4,338,374) |
|||||
Receivables from affiliates |
632,705 |
(175,698) |
|||||
Supplies inventories |
(49,712) |
(35,657) |
|||||
Prepaid and other current assets |
1,300,573 |
(1,489,956) |
|||||
Other assets |
(97,895) |
(204,838) |
|||||
Accounts payable |
(3,865,959) |
(1,791,968) |
|||||
Accrued liabilities |
1,249,407 |
3,810,422 |
|||||
Other current liabilities |
297,043 |
(2,330,737) |
|||||
Other liabilities |
256,129 |
3,087,988 |
|||||
Net cash provided by operating activities from continuing operations |
6,448,855 |
2,385,165 |
|||||
Net cash used in operating activities from discontinued operations |
(2,394,061) |
(454,338) |
|||||
Net cash provided by operating activities |
4,054,794 |
1,930,827 |
|||||
Investing activities: |
|||||||
Purchase of property and equipment |
(1,157,635) |
(1,810,180) |
|||||
Disposal of property and equipment |
130,745 |
— |
|||||
Proceeds from sale of equity investment |
— |
178,000 |
|||||
Distributions from affiliates |
1,626,614 |
2,061,937 |
|||||
Net cash provided by investing activities from continuing operations |
599,724 |
429,757 |
|||||
Net cash provided by investing activities from discontinued operations |
8,388,233 |
— |
|||||
Net cash provided by investing activities |
8,987,957 |
429,757 |
|||||
Financing activities: |
|||||||
Debt proceeds |
4,995,966 |
29,092,552 |
|||||
Debt payments |
(11,667,620) |
(24,560,683) |
|||||
Preferred noncontrolling interest dividends |
(566,096) |
(583,693) |
|||||
Preferred noncontrolling interest redemptions |
(870,000) |
— |
|||||
Distributions to noncontrolling interests |
(3,043,748) |
(2,879,989) |
|||||
Net cash (used in) provided by financing activities from continuing operations |
(11,151,498) |
1,068,187 |
|||||
Net cash used in financing activities from discontinued operations |
— |
(4,072,896) |
|||||
Net cash used in financing activities |
(11,151,498) |
(3,004,709) |
|||||
Net change in cash and cash equivalents |
1,891,253 |
(644,125) |
|||||
Cash and cash equivalents at beginning of period |
2,860,025 |
4,212,076 |
|||||
Cash and cash equivalents at end of period |
$ |
4,751,278 |
$ |
3,567,951 |
|||
Cash Paid for Interest and Income Taxes: |
|||||||
Interest expense |
$ |
1,280,000 |
$ |
1,604,256 |
|||
Interest expense, discontinued operations |
$ |
— |
$ |
168,733 |
|||
Income taxes, continuing operations |
$ |
— |
$ |
3,255,623 |
SOURCE Foundation HealthCare
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article